Business Description
Black Diamond Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US09203E1055
Share Class Description:
BDTX: Ordinary SharesDescription
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.9 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1.4 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | 1.5 | |||||
| 3-Year Book Growth Rate | -35.8 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.1 | |||||
| 9-Day RSI | 31.05 | |||||
| 14-Day RSI | 33.58 | |||||
| 6-1 Month Momentum % | -47.95 | |||||
| 12-1 Month Momentum % | -11.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.55 | |||||
| Quick Ratio | 5.55 | |||||
| Cash Ratio | 5.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.7 | |||||
| Shareholder Yield % | -17.4 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -64.83 | |||||
| ROA % | -48.01 | |||||
| ROIC % | -301.12 | |||||
| ROC (Joel Greenblatt) % | -355.5 | |||||
| ROCE % | -60.67 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.27 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| EV-to-EBIT | -0.42 | |||||
| EV-to-EBITDA | -0.42 | |||||
| EV-to-FCF | -0.56 | |||||
| Price-to-Net-Current-Asset-Value | 1.65 | |||||
| Price-to-Net-Cash | 1.71 | |||||
| Earnings Yield (Greenblatt) % | -238.1 | |||||
| FCF Yield % | -49.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BDTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Black Diamond Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.33 | ||
| Beta | 3.44 | ||
| Volatility % | 82.18 | ||
| 14-Day RSI | 33.58 | ||
| 14-Day ATR ($) | 0.177422 | ||
| 20-Day SMA ($) | 2.4325 | ||
| 12-1 Month Momentum % | -11.5 | ||
| 52-Week Range ($) | 2.09 - 7.66 | ||
| Shares Outstanding (Mil) | 56.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Black Diamond Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Black Diamond Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Black Diamond Therapeutics Inc Frequently Asked Questions
What is Black Diamond Therapeutics Inc(BDTX)'s stock price today?
The current price of BDTX is $2.19. The 52 week high of BDTX is $7.66 and 52 week low is $2.09.
When is next earnings date of Black Diamond Therapeutics Inc(BDTX)?
The next earnings date of Black Diamond Therapeutics Inc(BDTX) is 2025-03-12 Est..
Does Black Diamond Therapeutics Inc(BDTX) pay dividends? If so, how much?
Black Diamond Therapeutics Inc(BDTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers